Here are four points:
1. The study examines the safety and efficacy of InVivo Therapeutics’ Neuro-Spinal Scaffold in patients suffering from complete, thoracic spinal cord injury.
2. The patient has been enrolled at the Barnes-Jewish Hospital at Washington University Medical Center in St. Louis, which serves as a site of the study.
3. Wilson Ray, MD, an associate professor of neurosurgery and a member of The INSPIRE Study Steering Committee, implanted the scaffold in the patient.
4. The biodegradable Neuro-Spinal Scaffold is an investigational device that has received a ‘humanitarian use device’ designation from the FDA.
More articles on devices:
26 spine devices receive FDA 510(k) clearance in January
Medtronic, Stryker, Zimmer Biomet, DePuy Synthes, Smith & Nephew: Who had the best 2015? 32 things to know
Cervical artificial disc replacement & lateral spine surgery: 6 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
